The growth trajectory of the Neuroblastoma Market is underpinned by a rising market volume, which is expected to reach an estimated USD 559.08 million by 2035. This surge reflects a confluence of factors, including advancements in treatment methodologies, increased research funding, and heightened awareness of pediatric cancers. As the healthcare community pivots towards innovative and targeted...